Health and Fitness Health and Fitness
Mon, April 22, 2013
[ Mon, Apr 22nd 2013 ] - Market Wire
MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
[ Mon, Apr 22nd 2013 ] - Market Wire
PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
[ Mon, Apr 22nd 2013 ] - Market Wire
IMRIS to exhibit novel state-of-the-art VISIUS iCT imaging solution at AANS
[ Mon, Apr 22nd 2013 ] - Market Wire
Titan Medical Inc. Announces Significant Progress .. nt of its Single Incision Robotic Surgical System
[ Mon, Apr 22nd 2013 ] - Market Wire
Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
[ Mon, Apr 22nd 2013 ] - Market Wire
Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund
[ Mon, Apr 22nd 2013 ] - Market Wire
DARA and HELSINN Announce U.S. Launch of Gelclair .. ared Oral Gel for the Treatment of Oral Mucositis
[ Mon, Apr 22nd 2013 ] - Market Wire
Cheaper Gas, Airfare, Profits on Way as Commoditi .. s? - Top Small Cap Stock Focus Ahead of the Bell:
[ Mon, Apr 22nd 2013 ] - Market Wire
USANA Health Sciences Now Offering Prenatal Product
[ Mon, Apr 22nd 2013 ] - Market Wire
VentriPoint Announces Closing of Offering
[ Mon, Apr 22nd 2013 ] - Market Wire
Boston Therapeutics Addressing Unmet Medical Needs by Harnessing Complex Carbohydrate Chemistry
[ Mon, Apr 22nd 2013 ] - Market Wire
Novadaq to Release First Quarter 2013 Financial R .. sults On April 29, 2013-Conference Call to Follow
[ Mon, Apr 22nd 2013 ] - Market Wire
Implant Sciences' Quantum Sniffer Explosives and .. to Be Exhibited at 11th Annual Expo Seguridad Me
[ Mon, Apr 22nd 2013 ] - Market Wire
STAAR Surgical Announces First Quarter 2013 Results Release Date And Conference Call And Webcast
[ Mon, Apr 22nd 2013 ] - Market Wire
GSK and Theravance Announce Regulatory Submission for ANORO(TM) ELLIPTA(TM) (UMEC/VI) in Japan
Sun, April 21, 2013
[ Sun, Apr 21st 2013 ] - Market Wire
Galapagos discovers novel candidate drug to treat breast cancer
Fri, April 19, 2013
[ Fri, Apr 19th 2013 ] - Market Wire
Red Oak Partners Issues Open Letter to Digirad Co .. tion Shareholders About the Current Proxy Contest
[ Fri, Apr 19th 2013 ] - Market Wire
Ceregene Reports Data From Parkinson's Disease Phase 2b Study
[ Fri, Apr 19th 2013 ] - Market Wire
Novo Nordisk Unveils New U.S. Headquarters
[ Fri, Apr 19th 2013 ] - Market Wire
CML HealthCare Inc.'s Subsidiary, Hemostasis Refe .. rded Contract Extension with Isis Pharmaceuticals
[ Fri, Apr 19th 2013 ] - Market Wire
Ceapro Reports Full-Year 2012 Financial and Operating Results
[ Fri, Apr 19th 2013 ] - Market Wire
BioScrip Prices Underwritten Offering of Common Stock
[ Fri, Apr 19th 2013 ] - Market Wire
iTech Medical, Inc. Enters Into Letter of Intent .. tal Ventures Inc. in Respect of a Proposed Merger
[ Fri, Apr 19th 2013 ] - Market Wire
Varian Medical Systems and Paul Scherrer Institut .. ounce Collaboration on Motion Management for IMPT
[ Fri, Apr 19th 2013 ] - Market Wire
Omeros to Present Additional OMS302 Clinical Data .. the Annual ASCRS and ASOA Symposium and Congress
[ Fri, Apr 19th 2013 ] - Market Wire
Interim PILLAR II Results Reported During SAGES
Thu, April 18, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
Harwood Feffer LLP Announces Investigation of AdCare Health, Inc.
[ Thu, Apr 18th 2013 ] - Market Wire
Masimo to Report First Quarter 2013 Financial Results after Market Close on Thursday, May 2
[ Thu, Apr 18th 2013 ] - Market Wire
Cempra, Inc. to Report First Quarter 2013 Financi .. Host Conference Call and Webcast on April 25, 20
[ Thu, Apr 18th 2013 ] - Market Wire
Sarepta Therapeutics to Present Company Overview at the Needham Annual Healthcare Conference

Sarepta Therapeutics to Present Company Overview at the Needham Annual Healthcare Conference


Published on 2013-04-18 13:16:48 - Market Wire
  Print publication without navigation


April 18, 2013 16:05 ET

Sarepta Therapeutics to Present Company Overview at the Needham Annual Healthcare Conference

Webcast Accessible via Sarepta Therapeutics Website

CAMBRIDGE, MA--(Marketwired - Apr 18, 2013) - Sarepta Therapeutics (NASDAQ: [ SRPT ]), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the Needham & Company Annual Healthcare Conference in New York, NY on Tuesday, April 30, 2013 at 4:20 p.m. Eastern Time. Chris Garabedian, Sarepta's president and CEO, will be the presenter.

The presentation will be webcast live under the investor relations section of Sarepta Therapeutics' website at [ www.sareptatherapeutics.com ] and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. Sarepta aims to build a leading, independent biotech company dedicated to translating its RNA-based science into transformational therapeutics for patients who face significant unmet medical needs. For more information, please visit us at [ www.sareptatherapeutics.com ].


Contributing Sources